List of Tables
Table 1. Cancer Medication Market Trends
Table 2. Cancer Medication Market Drivers & Opportunity
Table 3. Cancer Medication Market Challenges
Table 4. Cancer Medication Market Restraints
Table 5. Global Cancer Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Medication Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cancer Medication Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cancer Medication Product Type
Table 9. Key Companies Time to Begin Mass Production of Cancer Medication
Table 10. Global Cancer Medication Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Medication as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cancer Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cancer Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cancer Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cancer Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cancer Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cancer Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cancer Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cancer Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cancer Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cancer Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cancer Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cancer Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cancer Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cancer Medication Sales Value by Region (2019-2024) & (%)
Table 27. Global Cancer Medication Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cancer Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cancer Medication Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cancer Medication Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Cancer Medication Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cancer Medication Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. HENGRUI Basic Information List
Table 37. HENGRUI Description and Business Overview
Table 38. HENGRUI Cancer Medication Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cancer Medication Business of HENGRUI (2019-2024)
Table 40. HENGRUI Recent Developments
Table 41. AstraZeneca Basic Information List
Table 42. AstraZeneca Description and Business Overview
Table 43. AstraZeneca Cancer Medication Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cancer Medication Business of AstraZeneca (2019-2024)
Table 45. AstraZeneca Recent Developments
Table 46. QILU Basic Information List
Table 47. QILU Description and Business Overview
Table 48. QILU Cancer Medication Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cancer Medication Business of QILU (2019-2024)
Table 50. QILU Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Cancer Medication Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cancer Medication Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. HANSOH Basic Information List
Table 57. HANSOH Description and Business Overview
Table 58. HANSOH Cancer Medication Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cancer Medication Business of HANSOH (2019-2024)
Table 60. HANSOH Recent Developments
Table 61. LUYE Basic Information List
Table 62. LUYE Description and Business Overview
Table 63. LUYE Cancer Medication Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cancer Medication Business of LUYE (2019-2024)
Table 65. LUYE Recent Developments
Table 66. Novartis Basic Information List
Table 67. Novartis Description and Business Overview
Table 68. Novartis Cancer Medication Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cancer Medication Business of Novartis (2019-2024)
Table 70. Novartis Recent Developments
Table 71. GuiZhou YiBai Basic Information List
Table 72. GuiZhou YiBai Description and Business Overview
Table 73. GuiZhou YiBai Cancer Medication Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cancer Medication Business of GuiZhou YiBai (2019-2024)
Table 75. GuiZhou YiBai Recent Developments
Table 76. Lunan Basic Information List
Table 77. Lunan Description and Business Overview
Table 78. Lunan Cancer Medication Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cancer Medication Business of Lunan (2019-2024)
Table 80. Lunan Recent Developments
Table 81. Eli Lilly and Company Basic Information List
Table 82. Eli Lilly and Company Description and Business Overview
Table 83. Eli Lilly and Company Cancer Medication Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cancer Medication Business of Eli Lilly and Company (2019-2024)
Table 85. Eli Lilly and Company Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Cancer Medication Downstream Customers
Table 89. Cancer Medication Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cancer Medication Product Picture
Figure 2. Global Cancer Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Cancer Medication Report Years Considered
Figure 5. Global Cancer Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Medication Revenue in 2023
Figure 7. Cancer Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antimetabolite Picture
Figure 9. Alkaloid Drugs Picture
Figure 10. Hormone Picture
Figure 11. Targeted Drug Picture
Figure 12. Platinum-based Drugs Picture
Figure 13. Other Picture
Figure 14. Global Cancer Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Cancer Medication Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Blood Cancer
Figure 17. Product Picture of Breast Cancer
Figure 18. Product Picture of Castrointestinal Cancer
Figure 19. Product Picture of Prostate Cancer
Figure 20. Product Picture of Respiratory/Lung Cancer
Figure 21. Product Picture of Other
Figure 22. Global Cancer Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Cancer Medication Sales Value Market Share by Application, 2023 & 2030
Figure 24. North America Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 25. North America Cancer Medication Sales Value by Country (%), 2023 VS 2030
Figure 26. Europe Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 27. Europe Cancer Medication Sales Value by Country (%), 2023 VS 2030
Figure 28. Asia Pacific Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 29. Asia Pacific Cancer Medication Sales Value by Country (%), 2023 VS 2030
Figure 30. South America Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 31. South America Cancer Medication Sales Value by Country (%), 2023 VS 2030
Figure 32. Middle East & Africa Cancer Medication Sales Value (2019-2030) & (US$ Million)
Figure 33. Middle East & Africa Cancer Medication Sales Value by Country (%), 2023 VS 2030
Figure 34. Key Countries/Regions Cancer Medication Sales Value (%), (2019-2030)
Figure 35. United States Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 36. United States Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 37. United States Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 38. Europe Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 39. Europe Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 40. Europe Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 41. China Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 42. China Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 43. China Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 44. Japan Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 45. Japan Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 46. Japan Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 47. South Korea Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 48. South Korea Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 49. South Korea Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 50. Southeast Asia Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 51. Southeast Asia Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 52. Southeast Asia Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 53. India Cancer Medication Sales Value, (2019-2030) & (US$ Million)
Figure 54. India Cancer Medication Sales Value by Type (%), 2023 VS 2030
Figure 55. India Cancer Medication Sales Value by Application (%), 2023 VS 2030
Figure 56. Cancer Medication Industrial Chain
Figure 57. Cancer Medication Manufacturing Cost Structure
Figure 58. Channels of Distribution (Direct Sales, and Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
